TOXOSTAT— 510(k) K944867

Substantially Equivalent

Bio-Whittaker, Inc., A Cambrex Co.

FDA 510(k) clearance K944867 for TOXOSTAT, Substantially Equivalent on 1996-05-14. Applicant: Bio-Whittaker, Inc., A Cambrex Co..

Clearance details

Applicant: Bio-Whittaker, Inc., A Cambrex Co.
Product code: Code LGD
Advisory panel: Microbiology
Date received: 1994-09-27
Decision date: 1996-05-14
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Walkersville, MD, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code LGD

product code LGD

Malfunction: 502
Total: 502

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.